课题基金 / 基金详情

OSTEOCLASTS--GLUCOCORTICOIDS AND APOPTOSIS

OSTEOCLASTS--GLUCOCORTICOIDS AND APOPTOSIS
破骨细胞——糖皮质激素和细胞凋亡
批准号:
2376657
负责人:
DAVID W. DEMPSTER
金额:
$12.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-03-01 至 1999-02-28

项目摘要

项目成果

DAVID W. DEMPSTER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The osteoclast plays a key role in the pathogenesis of osteoporosis and other metabolic bone diseases. While our understanding of the origin and regulation of the osteoclast has improved greatly in recent years, we are still almost completely ignorant of the fate of the osteoclast. As part of an investigation of the cellular mechanisms underlying glucocorticoid- induced osteoporosis, we have obtained evidence that the osteoclast exhibits apoptosis, or programmed cell death, a distinctive and deliberate type of cell death that differs fundamentally from necrosis in both its nature and biological significance. Prompted by this observation, this revised application is focused on the hypothesis that apoptosis plays a physiological role in determining osteoclast life span and, thereby, in the regulation of bone resorption. The significance of this hypothesis lies in the fact that it has the potential to provide a new conceptual framework for understanding important aspects of skeletal biology that are currently poorly understood, for example, the mode of action of glucocorticoids and estrogens on bone. The specific aims of this proposal are: 1) to test the hypothesis that in the presence of glucocorticoids, osteoclasts exhibit apoptosis in vitro, to elucidate the intracellular mechanisms underlying apoptosis in osteoclasts, and to probe for molecular markers of apoptosis in dying osteoclasts; 2) to examine how effects of glucocorticoids on osteoclast survival and activity are modified by the presence of osteoblasts and to determine the effects of glucocorticoids on osteoclast recruitment; 3) to determine whether mammalian and avian osteoclasts express glucocorticoid receptors; and 4) to test the hypothesis that osteoclasts exhibit apoptosis in vivo. These aims will be pursued using a combination of techniques, including the disaggregated osteoclast resorption assay, transmission electron microscopy of the osteoclasts, in situ hybridization, immunocytochemistry, and bone histomorphometry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--BONE HISTOMORPHOMETRY
  • 批准号:
    6347258
  • 项目类别:
  • 资助金额:
    $13.97万
  • 财政年份:
    2000
  • 负责人:
    DAVID W. DEMPSTER
  • 依托单位:
REGULATION OF DIFFERENTIATION AND DEATH OF HUMAN AND MURINE OSTEOCLASTS
  • 批准号:
    6347253
  • 项目类别:
  • 资助金额:
    $13.97万
  • 财政年份:
    2000
  • 负责人:
    DAVID W. DEMPSTER
  • 依托单位:
CORE--BONE HISTOMORPHOMETRY
  • 批准号:
    6201521
  • 项目类别:
  • 资助金额:
    $13.97万
  • 财政年份:
    1999
  • 负责人:
    DAVID W. DEMPSTER
  • 依托单位:
REGULATION OF DIFFERENTIATION AND DEATH OF HUMAN AND MURINE OSTEOCLASTS
  • 批准号:
    6201516
  • 项目类别:
  • 资助金额:
    $13.97万
  • 财政年份:
    1999
  • 负责人:
    DAVID W. DEMPSTER
  • 依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
  • 批准号:
    61602201
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    周雄辉
  • 依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
  • 批准号:
    81170309
  • 项目类别:
    面上项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2011
  • 负责人:
    颜桥
  • 依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
  • 批准号:
    30672394
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2006
  • 负责人:
    陆豪杰
  • 依托单位: